Not applicableStudy completedNCT01123434
What this trial is testing
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.
Who this might be right for
2 Years PSA Recurrence Rate
AstraZeneca 200